Literature DB >> 16256113

Synthesis of (di)nucleoside polyphosphates by the ubiquitin activating enzyme E1.

Maria A Günther Sillero1, Anabel de Diego, Eduardo Silles, Antonio Sillero.   

Abstract

Previous work from this laboratory had shown that ligases may catalyze the synthesis of (di)nucleoside polyphosphates. Here, we show that one of the enzymes of the proteasome system (E1 or the ubiquitin (Ub) activating enzyme, EC 6.3.2.19) catalyzes very effectively (k(cat) = 0.29+/-0.05 s(-1)) the transfer of AMP from the E-AMP-ubiquitin complex to tripolyphosphate or tetrapolyphosphate with formation of adenosine tetra- or pentaphosphate (p4A or p5A), respectively. Whereas the concomitant formation of AMP is stimulated by the presence of dithiothreitol in a concentration dependent manner, the synthesis of p4A is only slightly inhibited by this compound. Previous treatment of the enzyme (E1) with iodoacetamide inhibited only partially the synthesis of p4A. p4A can substitute for ATP as substrate of the reaction to generate the ubiquityl adenylate complex. A small amount of diadenosine pentaphosphate (Ap5A) was also synthesized in the presence of p4A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256113     DOI: 10.1016/j.febslet.2005.10.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.

Authors:  María J Pérez de Lara; Ana Guzmán-Aranguez; Rosa Gómez-Villafuertes; Javier Gualix; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-06-08       Impact factor: 3.765

2.  Presence of diadenosine polyphosphates in microdialysis samples from rat cerebellum in vivo: effect of mild hyperammonemia on their receptors.

Authors:  Javier Gualix; Rosa Gómez-Villafuertes; Jesús Pintor; Marta Llansola; Vicente Felipo; M Teresa Miras-Portugal
Journal:  Purinergic Signal       Date:  2013-08-13       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.